key: cord-0054446-pixfo3fd authors: Ma, Liang title: Industry news: 2020 high-impact publications in the BDM area date: 2021-01-05 journal: Biodes Manuf DOI: 10.1007/s42242-020-00123-2 sha: 449b4719d5e6fb7565b78ce815671c7211be2bd6 doc_id: 54446 cord_uid: pixfo3fd nan Although the world in 2020 is suffering from the COVID-19 pandemic, developments in bio-design and manufacturing (BDM) have not ceased. We have selected the most exciting progress in this flourishing area throughout 2020 from the three-dimensional (3D) bioprinting of different functional micro-organoids including kidneys to the manufacture of 3D tissues in the infinite universe. Remarkable technical breakthroughs have been seen in this area including noninvasive in vivo 3D bioprinting, intravital 3D bioprinting, single-cell printing, and rapid prototyping. Significant biomedical applications including human blood-brain barrier platforms, the noninvasive treatment of type 2 diabetes (T2D), and corpus cavernosa reconstructions have further benefited medical care development and our overall quality of life. Nature Communications: Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms An article titled 'Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms [1] ' published by YongTae Kim's research team from the Georgia Institute of Technology (USA) in Nature Communications provides us with a microphysiological platform that recapitulates the key structure and function of the human BBB and enables 3D mapping of nanoparticle distributions in vascular and perivascular regions. This model captures precisely 3D nanoparticle distributions at the cellular level and demonstrates distinct cellular uptake and blood-brain barrier (BBB) penetrations through receptor-mediated transcytosis. This BBB platform also presents a complementary in vitro model for animal approaches for prescreening drug candidates for the treatment of neurological diseases. Melissa H. Little's research team from Australia published an article entitled 'Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation [3] ' in Nature Materials. In the study, the authors apply extrusion-based 3D cellular bioprinting to deliver rapid and high-throughput generation of kidney organoids with highly reproducible cell number and viability. Automated extrusion-based bioprinting for kidney organoid production delivers improvements in throughput, quality control, scale and structure, facilitating in vitro and in vivo applications of stem cell-derived human kidney tissue. An article titled 'Recapitulating macro-scale tissue selforganization through organoid bioprinting [4] Nicola Elvassore's team from the University of Padova published an article titled 'Intravital three-dimensional bioprinting [7] ' in Nature Biomedical Engineering. The study shows that 3D cell-laden photosensitive polymer hydrogels can be bioprinted across, and within, tissues of live mice, using bio-orthogonal two-photon cycloaddition and crosslinking of polymers at wavelengths longer than 850 nm. Similarly, 3D bioprinting of donor-muscle-derived stem cells under the epimysium of hindlimb muscle in mice leads to the de novo formation of myofibres in the mice. Intravital 3D bioprinting might serve as an in vivo alternative to conventional bioprinting. In an article entitled 'High-definition single-cell printing: Cell-by-cell fabrication of biological structures [8] ' published by Pengfei Zhang and Adam R. Abate from the University of California in Advanced Materials, a novel microfluidic technology called high-definition single-cell printing was presented that can accurately print single cells from a mixture of multiple candidates. This bioprinter employs a highly miniaturized microfluidic sorter to deterministically select single cells of interest for printing, achieving an accuracy of ≈ 10 µm and speed of ≈ 100 Hz. This approach was shown to work well by fabricating intricate cell patterns with pre-defined features through selective single-cell printing. This printer was then used to synthesize well-defined spheroids with controlled composition and morphology. The speed, accuracy, and flexibility of this approach to advance bioprinting will enable new studies in organoid science, tissue engineering, and spatially targeted cell therapies. Research led by Xuetao Shi from the South China University of Technology and Chuanbin Mao from the University of Oklahoma published an article titled 'Functional reconstruction of injured corpus cavernosa using 3D-printed hydrogel scaffolds seeded with HIF-1α-expressing stem cells [9] ' in Nature Communications. These authors constructed heparincoated 3D-printed hydrogel scaffolds seeded with hypoxia inducible factor-1 alpha (HIF-1 alpha)-mutated musclederived stem cells (MDSCs) to develop bioengineered vascularized corpora. These bioengineered corpora scaffolds repair defects and recover penile erectile and ejaculation function successfully. This functional recovery restores the reproductive capability of injured male rabbits and demonstrates that the 3D-printed hydrogels with angiogenic cells hold great promise for penile reconstruction to restore male reproductive capability. Ivan R. Minev from the Technische Universität Dresden as well as Pavel Musienko from Saint-Petersburg State University and other researchers published an article titled 'Rapid prototyping of soft bioelectronic implants for use as neuromuscular interfaces [10] ' in Nature Biomedical Engineering. The study shows that soft biocompatible materials can be rapidly printed for the on-demand prototyping of customized electrode arrays well-adjusted to specific anatomical environments, functions, and experimental models. These printed bioelectronic interfaces allow for long-term integration and functional stability. This technology might enable personalized bioelectronics for neuroprosthetic applications. Yu Shrike Zhang from Harvard Medical School and Ali Khademhosseini from Terasaki Institute for Biomedical Innovation (TIBI) organized the special issue focus on the in vitro tissue models for BDM in 2020. From the Editorial titled 'Engineering in vitro Human Tissue Models through Bio-Design and Manufacturing [11] ' and a set of articles in the issue, we can know that the in vitro tissue models manufactured by 3D bioprinting or microfluidic based organ-on-chips technologies can provide a powerful tool for personalized medicine. Conflict of interest The author declares that he has no conflict of interest. Ethical approval This article does not contain any studies with human or animal subjects performed by the author. Microengineered human blood-brain barrier platform for understanding nanoparticle transport mechanisms Exposure to Static Magnetic and Electric Fields Treats Type 2 Diabetes Cellular extrusion bioprinting improves kidney organoid reproducibility and conformation Recapitulating macro-scale tissue self-organization through organoid bioprinting Magnetic levitational bioassembly of 3D tissue construct in space Intravital three-dimensional bioprinting High-definition single-cell printing: cell-by-cell fabrication of biological structures Functional reconstruction of injured corpus cavernosa using 3D-printed hydrogel scaffolds seeded with HIF-1alpha-expressing stem cells Rapid prototyping of soft bioelectronic implants for use as neuromuscular interfaces Engineering in vitro human tissue models through bio-design and manufacturing